safe peptide FAQ

Discard the vial and reconstitute fresh peptide. Even 8–12 hours at 20–25°C causes measurable potency loss (estimated 5–8% based on accelerated degradation studies), and you cannot visually confirm peptide integrity. Degraded ipamorelin looks identical to fresh solution. The financial loss of one vial is negligible compared to the research validity risk of using compromised peptide. For studies requiring precise dosing consistency, any temperature excursion above 8°C for more than 2 hours should trigger replacement.

Discard the vial immediately—do not attempt to use it. Cloudiness indicates protein aggregation from denaturation, which occurs when solvent was injected too forcefully, the vial was shaken instead of swirled, or temperature exceeded safe limits during storage or reconstitution. Floating particles are typically rubber stopper fragments from needle punctures or precipitated protein aggregates. Neither condition reverses with additional mixing, refrigeration, or filtration. Injecting particulate-contaminated or aggregated peptides introduces foreign matter into tissue, triggering immune responses and compromising research validity. The peptide has no residual bioactivity once aggregation occurs.

Use a purpose-built medical cooler that maintains 2–8°C for the entire transport duration. Standard ice packs and soft coolers do not maintain stable temperature—ice packs freeze reconstituted peptides if they contact the vial directly, and soft coolers allow temperature drift above 8°C within 90 minutes in warm environments. FRIO wallets use evaporative cooling and maintain 18–26°C, which is insufficient for reconstituted peptides but acceptable for lyophilised powder. For air travel, TSA permits medically necessary liquids in carry-on with documentation; never check reconstituted peptides in luggage, where cargo hold temperatures can reach 40°C. Plan transport under four hours total, and refrigerate immediately upon arrival.

Yellow, brown, or grey discoloration in lyophilised powder suggests oxidation, moisture contamination from a failed vacuum seal, or degradation during shipping. Lyophilised Adamax should appear white or off-white as a compressed cake. If discoloration is present, contact Real Peptides immediately—oxidized peptides have reduced or zero bioactivity even before reconstitution. Do not attempt to reconstitute discolored powder assuming mixing will restore it; oxidation is irreversible. Small cracks or a slightly uneven surface texture in the lyophilised cake are normal and do not indicate degradation, but color change always signals a compromised product.

Assume the peptide is compromised if room temperature exceeded 20°C for more than four hours. Peptides degrade exponentially faster at ambient temperature—oxidation accelerates, bacterial growth begins if preservative concentration drops below effective levels, and tertiary protein structure destabilizes. The solution may still appear clear, but potency loss of 30–60% is typical after 8–12 hours at room temperature. If the vial was out for fewer than two hours and room temperature stayed below 22°C, refrigerate immediately and use within 48 hours; beyond that window, discard and reconstitute a fresh vial. There is no reliable home test for potency—appearance alone cannot confirm bioactivity.

First, confirm you added the correct solvent volume. Underdissolved powder usually indicates you added too little water for the peptide mass present. If your calculations were correct and powder remains, gently roll the vial between your palms for 60 seconds without shaking. The warmth from your hands slightly increases molecular kinetic energy, which speeds passive diffusion. If powder still persists after rolling, let the vial sit at room temperature for an additional 10 minutes before refrigerating. Do not use heat to accelerate dissolution. Temperatures above 25°C begin denaturing the peptide. If the powder has not dissolved after 15 minutes total, contact your peptide supplier for a replacement vial.

Peptide hydrolysis accelerates exponentially with temperature. At 20–25°C, DSIP loses approximately 5–8% potency per day compared to <1% per day at 4°C. If the vial was unrefrigerated for 6–8 hours, potency loss is roughly 2–3%. Still usable but with reduced bioactivity. Beyond 12 hours at room temperature, potency drops below 85%, at which point research results become unreliable. There's no method to 'restore' lost potency. The cleaved peptide bonds cannot be re-formed.

Reconstituted peptide solutions are fragile during transport. If you must move a vial after reconstituting, use an insulated medical transport cooler with ice packs that maintain 2–8°C. Standard lunch-box coolers with loose ice are insufficient. Temperature fluctuations above 8°C accelerate degradation, and temperatures near 0°C risk partial freezing. Purpose-built insulin coolers work well for short trips up to 12 hours. For longer transport, use a laboratory specimen cooler with temperature data logging. Never transport reconstituted MOTS-C in checked luggage on flights. Cargo holds can drop below freezing at altitude. If you're traveling and need peptide access, consider using pre-filled syringes drawn under sterile conditions immediately before departure.

Do not shake the vial. Gently tilt it back and forth at a 45-degree angle. One tilt every 10 seconds for up to two minutes. Allowing gravity to move undissolved particles through the solution. If powder remains visible after this, the issue is usually insufficient bacteriostatic water volume, not slow dissolution. DSIP at 2mg per vial requires 2mL bacteriostatic water for complete dissolution; using 1mL leaves powder adhered to the vial bottom. Add the remaining volume using the same angled-injection technique.

The peptide is likely partially denatured, but not entirely destroyed. Refrigerate it immediately and use it within 7–10 days rather than the full 28-day window. Shortened stability timeline reduces the impact of structural damage. Visual inspection won't reveal denaturation; the solution will look identical to properly reconstituted DSIP. If research results are inconsistent or weaker than expected, shear denaturation is the probable cause. For critical experiments, discard the vial and reconstitute a fresh one correctly.

Stop using that vial for research applications where peptide integrity is critical. Shaking introduces two forms of mechanical stress: turbulent flow (which disrupts hydrogen bonds in the peptide backbone) and air incorporation (which accelerates oxidation of methionine residues). MOTS-C contains two methionine residues critical for mitochondrial ribosome binding. Oxidation at these sites reduces bioactivity without any visible change to the solution. If you shook the vial within the first 30 seconds of reconstitution, the damage is limited but not negligible. For low-stakes exploratory work, you can proceed with caution. For any application where dosing precision matters, discard the vial and start over.

Track the shipment in real-time and monitor transit duration relative to the insulation system's cold-life rating. Standard pharmaceutical insulated shippers maintain 2–8°C for 48 hours—if your shipment is delayed beyond this window, contact the supplier before the package arrives. Real Peptides monitors all in-transit peptide orders and proactively reaches out when delays exceed insulation performance specifications. If a delay occurs during extreme weather (summer heat waves, winter freezes), the compound integrity risk increases significantly. In these cases, request a temperature log review upon arrival—if the data logger shows sustained excursions above 8°C, request a replacement shipment rather than proceeding with a potentially denatured product. Research protocol validity depends on compound integrity; using compromised peptides wastes not just the material cost but the entire downstream experimental investment.

Reduce the GHS dose first. Nausea from growth hormone secretagogues is dose-dependent and typically resolves at 50–60% of the initial dose. Adamax rarely causes nausea at therapeutic doses (0.25–0.5mg), so if nausea appears only after adding Ipamorelin or Hexarelin, the GHS is the likely culprit. Start Ipamorelin at 100mcg instead of 200–300mcg and titrate upward over 7–10 days. Administering GHS on an empty stomach exacerbates nausea; taking it 30–60 minutes after a small protein-rich meal (20–30g protein) blunts ghrelin-induced gastric motility changes without impairing GH release. If nausea persists at reduced doses, substitute the GHS with a non-ghrelin lipolytic agent like AOD9604, which has no gastric side effects.

International Cerebrolysin shipping introduces customs clearance delays, extended transit times, and regulatory compliance requirements that significantly increase temperature control complexity. Most international shipments require 72–96 hour cold-life insulation systems and often involve specialized cold-chain logistics providers rather than standard carriers. Customs holds can extend transit by 3–7 days unpredictably, during which packages sit in non-climate-controlled inspection facilities. For international orders, work with suppliers experienced in cross-border pharmaceutical logistics who can provide country-specific import documentation, properly classified shipping declarations, and insulation systems rated for extended transit. Real Peptides coordinates international peptide shipments through partners with customs brokerage expertise, but researchers should verify destination country regulations regarding neuropeptide research compounds before ordering—some jurisdictions restrict or prohibit importation of brain-derived biologics regardless of intended research use.

The Adamax + Tesofensine stack requires only two Adamax injections daily (Tesofensine is oral). If two injections daily is still excessive, switch to once-daily Adamax at 0.5–0.75mg in the morning alongside Tesofensine and add oral 5-Amino-1MQ for mitochondrial support. This reduces the protocol to one injection and two oral doses. The tradeoff: losing the second Adamax dose eliminates the afternoon lipolytic window, reducing total daily fat oxidation by approximately 20–30% compared to twice-daily dosing. For research models where injection compliance is the limiting factor, one injection is better than zero. But the efficacy ceiling drops accordingly.

Arrange for an authorized recipient at the delivery address or request the package be held at a carrier facility with climate-controlled storage for pickup. Most carriers offer "Hold for Pickup" services where packages are kept at a distribution center rather than dispatched for home delivery—this eliminates last-mile porch exposure entirely. Alternatively, specify delivery to a workplace, university mailroom, or research facility where receiving staff can immediately transfer the package to refrigeration. For residential deliveries, consider installing a climate-controlled delivery box (models like the Yale Smart Delivery Box or PackageGuard maintain interior temperatures and provide secure storage) or coordinate delivery for a specific day when you will be home. The worst scenario is allowing the carrier to leave a cold-chain package unattended outdoors—every hour of ambient exposure increases denaturation probability exponentially.

Don't. You're creating direct receptor competition without additional benefit. Both Melanotan 2 MT2 10mg and Adamax bind melanocortin receptors, but MT2 has broader receptor activity (MC1R, MC3R, MC4R) while Adamax is MC4R-selective. When both compounds compete for the same MC4R binding sites, neither achieves full receptor occupancy. You dilute Adamax's fat oxidation effect while adding MT2's pigmentation and erectile side effects. The clinical data is clear: combining two ligands for the same receptor produces less than additive effects. It's subtractive in most cases due to competitive inhibition kinetics. If pigmentation is the research goal, use MT2 alone. If fat oxidation is the goal, use Adamax with a non-melanocortin compound.

Do not use the product—contact the supplier immediately and document the condition with photos showing packaging state and any remaining gel pack status. A Cerebrolysin vial that feels room temperature or warm has almost certainly exceeded the 8°C threshold for long enough to denature the peptide complex. Even if the vial appears clear and sterile, the neuroprotective mechanism is likely compromised. Reputable suppliers like Real Peptides include temperature data loggers in shipments specifically to resolve these situations—request the temperature log data to confirm whether excursions occurred and for how long. If the internal temperature exceeded 8°C for more than 2–4 hours cumulatively, the peptide should be replaced rather than used in research protocols where outcome validity depends on compound integrity.

Prioritize the Adamax + Tesofensine stack for maximum short-term efficacy. Tesofensine's thermogenic effect (10–15% resting metabolic rate increase) and appetite suppression appear within 3–5 days of initiation, compared to GH-mediated lipolysis, which requires 2–3 weeks to upregulate beta-3 adrenergic receptor density. The Phase II Tesofensine trial showed mean weight loss of 4.5% at 4 weeks on 0.5mg daily. Faster onset than any peptide monotherapy. Pair it with twice-daily Adamax to maximize acute lipolytic signaling during the compressed research window. AOD9604 and MOTS-C require 4–6 weeks to demonstrate full metabolic reprogramming effects, making them suboptimal for short timelines.